EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of advanced Hodgkins disease with COPP-ABVD and COPP-ABV-IMEP and consolidating radiotherapy A report from the German Hodgkins Lymphoma Study Group



Treatment of advanced Hodgkins disease with COPP-ABVD and COPP-ABV-IMEP and consolidating radiotherapy A report from the German Hodgkins Lymphoma Study Group



Onkologie 23(Sonderheft 7): 71, October




(PDF 0-2 workdays service: $29.90)

Accession: 035980852

Download citation: RISBibTeXText



Related references

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial. Annals of Oncology 15(2): 276-282, 2004

Comparison of COPP/ABVD and COPP/ABV/IMEP in the treatment of Hodgkins Disease Results of HD5 and HD6 studies of the German Hodgkin Study Group. British Journal of Haematology 93(SUPPL 2): 372, 1996

The rapidly alternating scheme COPP-ABV-IMEP is equally effective as COPP-ABVD in advanced stages of Hodgkins disease Results of the HD6 study of the GHSG. Blood. 88(10 Suppl. 1 Part 1-2): 92a, 1996

Randomized comparison of COPP/ABVD and COPP/ABV/IMEP in the treatment of Hodgkins disease Results of HD5 and HD6 studies. Onkologie 18(SUPPL 2): 76, 1995

Rapidly alternating COPP + ABV + IMEP is equally effective as alternating COPP + ABVD for Hodgkins disease Final results of two randomized trials for intermediate and advanced stages. Blood 90(10 SUPPL 1 PART 1): 586A, Nov 15, 1997

Treatment of advanced-stage Hodgkins disease with COPP and COPP alternating with ABVD. British Journal of Haematology 102(1): 118, July 1, 1998

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5. Journal of Clinical Oncology 20(2): 476-484, 2002

Randomized comparison of COPP/ABVD vs dose- and time-escalated COPP/ABVD with GM-CSF support for advanced Hodgkins disease. Blood 90(10 SUPPL 1 PART 1): 389A, Nov 15, 1997

Alternating COPP + ABVD versus rapidly alternating COPP+ABV+IMEP for Hodgkins disease. Annals of Hematology 67(SUPPL ): A74, 1993

Long-term results of a randomized trial comparing alternating COPP+ABVD versus rapidly alternating COPP+ABV+IMEP followed by extended field radiation in Hodgkins disease. Onkologie 23(Sonderheft 7): 70, October, 2000

Interim analysis of the HD9 study of the German Hodgkin study group -BEACOPP is more effective than COPP-ABVD in advanced stage Hodgkins disease. Blood 90(10 SUPPL 1 PART 1): 339A, Nov 15, 1997

BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group. Leukemia & Lymphoma 46(11): 1561-1567, 2005

Results of EF- versus IF-RT after 2 cycles of COPP/ABVD for intermediate stage Hodgkins disease The interim analysis of the HD8 trial of the German Hodgkin Study Group. Cancer Journal 6(2): 101-102, March-April, 2000

Cost-effectiveness analysis model for COPP/ABVD and BEACOPP escalated regimens of the German HD9 trial for advanced stages of Hodgkins disease. Blood 96(11 Part 1): 435a, November 16, 2000

Randomized comparison of COPOP/ABVD vs dose- and time-escalated COPP/ABVD with GM-CSF support for advanced Hodgkins disease. Blood 92(10 SUPPL 1 PART 1-2): 315A, Nov 15, 1998